Hong Kong Stock Announces Nuggets | Cyrus's total vehicle sales in December were 63,700 vehicles, up 53.54% year-on-year

Important matters:

“Shanhai‧Medical Big Model” empowers Yunzhisheng (09678) to win over 20 million regional medical cooperation orders

Colombotai Bio-B (06990) core product TROP2 ADC lucan satuzumab (SAC-TMT) combined immunotherapy pabolizumab first-line treatment of PD-L1-positive locally advanced or metastatic non-small cell lung cancer was recognized as a breakthrough therapy by NMPA

Silicon Intelligence (03696) and Schweier reached a multi-year anti-tumor drug research cooperation worth US$888 million

Hehuang Pharmaceutical (00013) initiated phase III of the ongoing study of surufatinib combined with carelizumab for the treatment of primary pancreatic ductal adenocarcinoma

Cully Pharmaceutical-B (01672) announced that ASC30 was approved by the US FDA for the 13-week phase II study in diabetic subjects

FuRui Medical Technology (01696) has been re-authorized to inject botulinum toxin type A and has passed the quality standard inspection of the China Food and Drug Administration Research Institute

Cansino Biotech (06185): 24-valent pneumococcal polysaccharide conjugate vaccine (CRM197/tetanus toxin) approved for clinical trials in China

Shijiyao Group (02005): Obtained drug production registration approval for perindopril amlodipine tablets (III) (perindopril arginine 10mg, amlodipine benzenesulfonate 5mg)

Shunyu Optical Technology (02382): It is proposed to split the Group's automotive-related optical business and independently list it on the main board of the Hong Kong Stock Exchange Limited

Dongyangyang Pharmaceutical (06887): HECN30227 has completed the enrollment of the first domestic test subjects

Haitian International (01882) subsidiary plans to sell 100% of Guohua Machinery's shares for 342 million yuan

Yuexiu Real Estate (00123) subsidiary plans to sell a total of 73.74% of Hangzhou Yuexiu Real Estate's real interests

CIMC World Alliance, a subsidiary of CIMC Group (02039), plans to introduce strategic investors through capital increases and stock expansion and the transfer of a small number of old shares

Operating performance:

Chifeng Gold (06693) is profitable. The net profit for the year is expected to be about 3 billion yuan to 3.2 billion yuan, an increase of about 70% to 81% over the same period last year

Corning Hospital (02120) The number of outpatients in 2025 was about 720,000, an increase of 29% over the same period last year

Cyrus (09927) sold a total of 63,700 vehicles in December, up 53.54% year-on-year

The equity power generation capacity of Cooperative New Energy (00182) in December was 790.32 GWh

Country Garden (02007)'s contract sales amount attributable to the company's shareholders' equity in December was about 2.69 billion yuan